Evidence map›Paper›PMID 38766268›Full record

ArticlebioRxiv : the preprint server for biology2024

Automated Cytometric Gating with Human-Level Performance Using Bivariate Segmentation.

Jiong Chen, Matei Ionita, Yanbo Feng, Yinfeng Lu, Patryk Orzechowski, Sumita Garai, Kenneth Hassinger, Jingxuan Bao, Junhao Wen, Duy Duong-Tran and 9 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Jiong ChenDepartment of Bioengineering, University of Pennsylvania School of Engineering and Applied Science, PA, USA.
Matei IonitaDepartment of Systems Pharmacology & Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, PA, USA.
Yanbo FengDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, PA, USA.
Yinfeng LuDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, PA, USA.
Patryk OrzechowskiDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, PA, USA.
Sumita GaraiDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, PA, USA.
Kenneth HassingerDepartment of Systems Pharmacology & Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, PA, USA.
Jingxuan BaoDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, PA, USA.
Junhao WenLaboratory of AI and Biomedical Science, Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC, University of Southern California, CA, USA.
Duy Duong-TranDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, PA, USA.
Joost WagenaarDepartment of Systems Pharmacology & Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, PA, USA.
Michelle L McKeagueDepartment of Systems Pharmacology & Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, PA, USA.
Mark M PainterDepartment of Systems Pharmacology & Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, PA, USA.
Divij MathewDepartment of Systems Pharmacology & Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, PA, USA.
Ajinkya PattekarDepartment of Systems Pharmacology & Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, PA, USA.
Nuala J MeyerDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
E John WherryDepartment of Systems Pharmacology & Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, PA, USA.
Allison R GreenplateDepartment of Systems Pharmacology & Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, PA, USA.
Li ShenDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, PA, USA.

Funding

Ultrascale Machine Learning to Empower Discovery in Alzheimers Disease BiobanksU01AG068057 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Christos Davatzikos, Heng Huang · 2020 to 2026
$20.7M
Biomedical Image Computing and Informatics ClusterS10OD023495 · OD · UNIVERSITY OF PENNSYLVANIA · PI DAVATZIKOS, CHRISTOS · 2017 to 2017
$1.9M
NIA NIH HHS U01 AG068057NIH HHS S10 OD023495
6 · The paper itself

Abstract

Recent advances in cytometry technology have enabled high-throughput data collection with multiple single-cell protein expression measurements. The significant biological and technical variance between samples in cytometry has long posed a formidable challenge during the gating process, especially for the initial gates which deal with unpredictable events, such as debris and technical artifacts. Even with the same experimental machine and protocol, the target population, as well as the cell population that needs to be excluded, may vary across different measurements. To address this challenge and mitigate the labor-intensive manual gating process, we propose a deep learning framework UNITO to rigorously identify the hierarchical cytometric subpopulations. The UNITO framework transformed a cell-level classification task into an image-based semantic segmentation problem. For reproducibility purposes, the framework was applied to three independent cohorts and successfully detected initial gates that were required to identify single cellular events as well as subsequent cell gates. We validated the UNITO framework by comparing its results with previous automated methods and the consensus of at least four experienced immunologists. UNITO outperformed existing automated methods and differed from human consensus by no more than each individual human. Most critically, UNITO framework functions as a fully automated pipeline after training and does not require human hints or prior knowledge. Unlike existing multi-channel classification or clustering pipelines, UNITO can reproduce a similar contour compared to manual gating for each intermediate gating to achieve better interpretability and provide post hoc visual inspection. Beyond acting as a pioneering framework that uses image segmentation to do auto-gating, UNITO gives a fast and interpretable way to assign the cell subtype membership, and the speed of UNITO will not be impacted by the number of cells from each sample. The pre-gating and gating inference takes approximately 2 minutes for each sample using our pre-defined 9 gates system, and it can also adapt to any sequential prediction with different configurations.

Identifiers

PMID38766268
PMCPMC11100732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.